Full year 2025 financial guidance excludes ... Steve Cutler commented, "ICON continues to navigate dynamic clinical development market conditions, as trial activity has been impacted by cautious ...

This discrepancy led to market reactions as it fell short of ... For detailed insights into ICON's financial health and growth prospects, investors can access the full Pro Research Report ...